Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
Thromb Haemost. 2008 Jul;100(1):38-44. doi: 10.1160/TH07-11-0659.
Thromb Haemost. 2008.
PMID: 18612536
High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects.
Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJ, van der Meer J.
Folkeringa N, et al.
Br J Haematol. 2007 Jul;138(1):110-6. doi: 10.1111/j.1365-2141.2007.06624.x.
Br J Haematol. 2007.
PMID: 17555454
Free article.
Item in Clipboard
Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study.
Folkeringa N, Korteweg FJ, Veeger NJ, Middeldorp S, Hamulyak K, Prins MH, Erwich JJ, Büller HR, van der Meer J.
Folkeringa N, et al.
Thromb Res. 2009;123(3):511-4. doi: 10.1016/j.thromres.2008.02.014. Epub 2008 May 2.
Thromb Res. 2009.
PMID: 18455758
No abstract available.
Item in Clipboard
Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations.
Coppens M, Folkeringa N, Teune MJ, Hamulyák K, van der Meer J, Prins MH, Büller HR, Middeldorp S.
Coppens M, et al. Among authors: folkeringa n.
J Thromb Haemost. 2007 Jul;5(7):1444-8. doi: 10.1111/j.1538-7836.2007.02586.x. Epub 2007 Apr 16.
J Thromb Haemost. 2007.
PMID: 17439630
Free article.
Item in Clipboard
Fetal loss in women with hereditary thrombophilic defects and concomitance of other thrombophilic defects: a retrospective family study.
Korteweg FJ, Folkeringa N, Brouwer JL, Erwich JJ, Holm JP, van der Meer J, Veeger NJ.
Korteweg FJ, et al. Among authors: folkeringa n.
BJOG. 2012 Mar;119(4):422-30. doi: 10.1111/j.1471-0528.2011.03264.x.
BJOG. 2012.
PMID: 22324918
Free article.
Item in Clipboard
Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women.
Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJ, Holm JP, van der Meer J.
Folkeringa N, et al.
Br J Haematol. 2007 Feb;136(4):656-61. doi: 10.1111/j.1365-2141.2006.06480.x.
Br J Haematol. 2007.
PMID: 17223916
Free article.
Clinical Trial.
Item in Clipboard
Prevalence of parental thrombophilic defects after fetal death and relation to cause.
Korteweg FJ, Erwich JJHM, Folkeringa N, Timmer A, Veeger NJGM, Ravisé JM, Holm JP, van der Meer J.
Korteweg FJ, et al. Among authors: folkeringa n.
Obstet Gynecol. 2010 Aug;116(2 Pt 1):355-364. doi: 10.1097/AOG.0b013e3181e66d58.
Obstet Gynecol. 2010.
PMID: 20664396
Free article.
Clinical Trial.
Item in Clipboard
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Kaandorp SP, Goddijn M, van der Post JA, Hutten BA, Verhoeve HR, Hamulyák K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DN, Büller HR, van der Veen F, Middeldorp S.
Kaandorp SP, et al. Among authors: folkeringa n.
N Engl J Med. 2010 Apr 29;362(17):1586-96. doi: 10.1056/NEJMoa1000641. Epub 2010 Mar 24.
N Engl J Med. 2010.
PMID: 20335572
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite